ANAs were associated with persistent symptoms of fatigue and dyspnea [194], antineuronal antibodies in CSF and serum with cognitive impairment [195], and anti-IFN-α2 or anti-IFN-λ autoantibodies with respiratory symptoms of LC [190,197]. The gene discussed is IFNA2; the disease is laryngotracheoesophageal cleft.